Inventor · disambiguated record
Steven A. Rosenberg
Also filed as: ROSENBERG STEVEN · ROSENBERG STEVEN A · ROSENBERG STEVEN AARON
164 granted patents·65 pending applications·8,056 citations·filing 1984–2025
99Inventor score
Top patents by PatentIndex Score
229 records- 0199US4690915AAdoptive immunotherapy as a treatment modality in humansUS HEALTH·Filed 1985·Granted Sep 1, 1987·753 cites·11 claims
- 0298US10166255B2Intracellular genomic transplant and methods of therapyUNIV MINNESOTA·Filed 2016·Granted Jan 1, 2019·43 cites·31 claims
- 0398US9074185B2Adoptive cell therapy with young T cellsUS HEALTH·Filed 2013·Granted Jul 7, 2015·131 cites·11 claims
- 0498US8383099B2Adoptive cell therapy with young T cellsUS HEALTH·Filed 2010·Granted Feb 26, 2013·274 cites·22 claims
- 0598US5399346AGene therapyUS ARMY·Filed 1994·Granted Mar 21, 1995·1.7k cites·14 claims
- 0697US9844569B2Methods of producing enriched populations of tumor reactive T cells from peripheral bloodUS HEALTH·Filed 2013·Granted Dec 19, 2017·112 cites·25 claims
- 0797US8088379B2Modified T cell receptors and related materials and methodsROBBINS PAUL F·Filed 2007·Granted Jan 3, 2012·127 cites·31 claims
- 0897US7749719B2Melanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 2007·Granted Jul 6, 2010·34 cites·6 claims
- 0997US5840839AAlternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded thereinUS HEALTH·Filed 1996·Granted Nov 24, 1998·242 cites·20 claims
- 1097US4876197AEukaryotic regulatable transcriptionCHIRON CORP·Filed 1985·Granted Oct 24, 1989·248 cites·14 claims
- 1196US11434272B2Anti-human papillomavirus 16 E7 T cell receptorsUS HEALTH·Filed 2020·Granted Sep 6, 2022·5 cites·20 claims
- 1296US11266692B2Intracellular genomic transplant and methods of therapyUNIV MINNESOTA·Filed 2020·Granted Mar 8, 2022·3 cites·19 claims
- 1396US11208456B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2020·Granted Dec 28, 2021·8 cites·36 claims
- 1496US11154574B2Tumor infiltrating lymphocytes and methods of therapyUNIV MINNESOTA·Filed 2020·Granted Oct 26, 2021·8 cites·12 claims
- 1596US10544392B2Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral bloodUS HEALTH·Filed 2016·Granted Jan 28, 2020·25 cites·16 claims
- 1696US10406177B2Modified cells and methods of therapyUNIV MINNESOTA·Filed 2016·Granted Sep 10, 2019·18 cites·23 claims
- 1796US9624306B2Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancerUS HEALTH·Filed 2016·Granted Apr 18, 2017·17 cites·16 claims
- 1896US9359447B2Anti-mesothelin chimeric antigen receptorsUS HEALTH·Filed 2013·Granted Jun 7, 2016·44 cites·27 claims
- 1996US9266960B2Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancerMORGAN RICHARD A·Filed 2012·Granted Feb 23, 2016·47 cites·2 claims
- 2096US8034334B2Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapyUS HEALTH·Filed 2003·Granted Oct 11, 2011·362 cites·18 claims
- 2196US5844075AMelanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 1995·Granted Dec 1, 1998·180 cites·14 claims
- 2296USRE35749EConstructs of glyceraldehyde-3-phosphate dehydrogenase promoter and methods for expressing genes using said constructsCHIRON CORP·Filed 1996·Granted Mar 17, 1998·143 cites·4 claims
- 2396US4880734AEukaryotic regulatable transcriptionCHIRON CORP·Filed 1986·Granted Nov 14, 1989·243 cites·21 claims
- 2495US11077182B2Methods of preparing anti-human papillomavirus antigen T cellsUS HEALTH·Filed 2020·Granted Aug 3, 2021·3 cites·24 claims
- 2595US10322146B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2017·Granted Jun 18, 2019·17 cites·30 claims
- 2695US9855298B2Methods of conditioning patients for T cell therapyKITE PHARMA INC·Filed 2016·Granted Jan 2, 2018·80 cites·30 claims
- 2795US8465743B2Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancerROSENBERG STEVEN A·Filed 2010·Granted Jun 18, 2013·184 cites·12 claims
- 2895US8211422B2Chimeric receptor genes and cells transformed therewithESHHAR ZELIG·Filed 1995·Granted Jul 3, 2012·240 cites·30 claims
- 2995US5994523AMelanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 1998·Granted Nov 30, 1999·130 cites·6 claims
- 3095US5126132ATumor infiltrating lymphocytes as a treatment modality for human cancerUS HEALTH·Filed 1989·Granted Jun 30, 1992·171 cites·6 claims
- 3195US5094951AProduction of glucose oxidase in recombinant systemsCHIRON CORP·Filed 1989·Granted Mar 10, 1992·370 cites·35 claims
- 3294US11147837B2Modified cells and methods of therapyUNIV MINNESOTA·Filed 2016·Granted Oct 19, 2021·6 cites·49 claims
- 3394US10870687B2Anti-human papillomavirus 16 E7 T cell receptorsUS HEALTH·Filed 2018·Granted Dec 22, 2020·6 cites·24 claims
- 3494US10611816B2Anti-KRAS-G12D T cell receptorsUS HEALTH·Filed 2017·Granted Apr 7, 2020·9 cites·17 claims
- 3594US10174098B2Anti-human papillomavirus 16 E7 T cell receptorsUS HEALTH·Filed 2015·Granted Jan 8, 2019·19 cites·31 claims
- 3694US9128080B2Modified T cell receptors and related materials and methodsROBBINS PAUL F·Filed 2011·Granted Sep 8, 2015·18 cites·18 claims
- 3794US8822196B2Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancerUS HEALTH·Filed 2013·Granted Sep 2, 2014·21 cites·19 claims
- 3894US7785797B2Methods and compositions for diagnosing and monitoring transplant rejectionXDX INC·Filed 2009·Granted Aug 31, 2010·20 cites·8 claims
- 3994US5874560AMelanoma antigens and their use in diagnostic and therapeutic methodsUS HEALTH·Filed 1994·Granted Feb 23, 1999·95 cites·1 claims
- 4094US5089398AEnhanced yeast transcription employing hybrid GAPDH promoter region constructsCHIRON CORP·Filed 1989·Granted Feb 18, 1992·145 cites·8 claims
- 4193US9522955B2Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancerUS HEALTH·Filed 2014·Granted Dec 20, 2016·19 cites·16 claims
- 4293US9345748B2Anti-SSX-2 T cell receptors and related materials and methods of useMORGAN RICHARD A·Filed 2011·Granted May 24, 2016·32 cites·23 claims
- 4393US8785601B2T cell receptors and related materials and methods of useROSENBERG STEVEN A·Filed 2010·Granted Jul 22, 2014·34 cites·14 claims
- 4493US8287857B2Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapyDUDLEY MARK E·Filed 2011·Granted Oct 16, 2012·88 cites·26 claims
- 4593US8216565B2GP100-specific T cell receptors and related materials and methods of useRESTIFO NICHOLAS P·Filed 2008·Granted Jul 10, 2012·32 cites·9 claims
- 4693US7879556B2Methods and compositions for diagnosing and monitoring transplant rejectionXDX INC·Filed 2010·Granted Feb 1, 2011·15 cites·8 claims
- 4792US10912797B2Tumor infiltrating lymphocytes and methods of therapyUNIV MINNESOTA·Filed 2018·Granted Feb 9, 2021·9 cites·33 claims
- 4892US8556882B2Inducible interleukin-12MORGAN RICHARD A·Filed 2010·Granted Oct 15, 2013·30 cites·26 claims
- 4992US7915036B2Compositions comprising T cell receptors and methods of use thereofUS HEALTH·Filed 2004·Granted Mar 29, 2011·30 cites·11 claims
- 5091US11401503B2Methods of growing tumor infiltrating lymphocytes in gas-permeable containersUS HEALTH·Filed 2018·Granted Aug 2, 2022·8 cites·13 claims
Showing the top 50 of 229 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Steven A. Rosenberg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →